Stock Price
1,750.30
Daily Change
16.80 0.97%
Monthly
-0.39%
Yearly
-3.06%
Q2 Forecast
1,584.75

Sun Pharmaceuticals reported INR113.32B in Cash and Equivalent for its fiscal quarter ending in March of 2025.





Cash And Equivalent Change Date
Aspen Pharmacare ZAR 6.41B 5.93B Jun/2025
Bharat Petroleum INR 137.44B 131.86B Sep/2025
Cipla INR 7.96B 39.9M Sep/2025
Dr.Reddys Laboratories INR 18.66B 8.75B Dec/2025
Jiangsu Hengrui CNY 40.96B 591.41M Dec/2025
Sh Fosun Pharma CNY 11.48B 1.48B Sep/2025
Sun Pharmaceuticals INR 113.32B 33.19B Mar/2025
UPL INR 41.52B 53.85B Sep/2025